Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,888.50 -24.50 (-1.28%)

Bid:

1,888.50

Ask:

1,889.00

Spread: 0.50 (0.026%)

Market Cap: £75.74b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

Bharat, GSK to halve price of malaria vaccine by 2028

LONDON, June 25 (Reuters) - Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to $5 per dose by 2028, more than halving ...

EMA accepts marketing authorisation application for GSK's linerixibat

(Sharecast News) - GSK said on Monday that the European Medicines Agency has accepted its marketing authorisation application for linerixibat, an inve...

GSK drug to treat itch caused by liver disease accepted for EU review

(Alliance News) - GSK PLC on Monday said linerixibat has been accepted for review by the European Medicines Agency for the treatment of intense itchin...

UK's FTSE 100 sees first weekly fall in six; Middle East tensions in focus

FTSE 100 down 0.2%, FTSE 250 adds 0.4% *

LONDON MARKET CLOSE: FTSE 100 underperforms Europe despite Iran talks

(Alliance News) - London's FTSE 100 faded into the close on Friday, ending lower, as weak retail sales data and falls in heavyweight oil and drug stoc...

Japan accepts GSK application for expanded use of RSV vaccine Arexvy

(Alliance News) - GSK PLC on Friday announced that Japan has accepted a regulatory application to expand the use of its respiratory syncytial virus [R...

GSK hoping to expand Arexvy usage in Japan

(Sharecast News) - Japanese regulators have accepted GSK's application to expand the use of its RSV vaccine, Arexvy, to the entire adult population.

Kennedy's new US vaccine panel to discuss measles shot for children

Panel to vote on RSV and flu shot recipients *